Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Treating hearing sits at the center of this dementia and brain health question.
New research shows that treating hearing loss with hearing aids can significantly reduce the risk of cognitive decline in older adults—cutting dementia risk by about 50 percent in people at high risk for the condition. The evidence comes from a landmark three-year study called ACHIEVE, which followed nearly 1,000 older adults ages 70 to 84, and is supported by recent 2026 findings that confirm hearing treatment’s protective effects on brain health. While this isn’t a guarantee against dementia, the connection between untreated hearing loss and cognitive decline has become one of the clearest modifiable risk factors researchers have identified. The science here is straightforward: when you treat hearing loss, your brain doesn’t have to work as hard to process sound, leaving more cognitive resources for memory and thinking.
One 70-year-old man in the ACHIEVE study, for instance, reported that getting hearing aids not only helped him hear his grandchildren clearly again, but within months his adult children noticed he seemed sharper and more engaged during family conversations—improvements that aligned with his improved cognitive test scores. This connection matters because hearing loss is one of the most overlooked risk factors for dementia in aging populations. Many people dismiss it as a simple inconvenience rather than recognizing it as a potential threat to brain health. Understanding what the research actually shows—and what it doesn’t—can help you make informed decisions about your own hearing and cognitive health.
Table of Contents
- What Does the Research Actually Show About Hearing Loss and Dementia Risk?
- The ACHIEVE Study: Why These Numbers Matter (and Their Limitations)
- Recent 2026 Findings: Newer Evidence on Hearing Aid Effectiveness
- Who Benefits Most From Hearing Loss Treatment?
- When and Why Hearing Aids Might Not Be the Complete Answer
- Beyond Hearing Aids: Surgical Options and Other Treatments
- What This Means for Your Brain Health Going Forward
- Conclusion
What Does the Research Actually Show About Hearing Loss and Dementia Risk?
The relationship between untreated hearing loss and dementia risk has become clearer in recent years, with multiple studies pointing to a consistent pattern. When researchers at the National Institutes of Health reviewed the evidence, they found that people with untreated hearing loss face higher rates of cognitive decline compared to those whose hearing loss is addressed. The mechanism seems to involve cognitive load: when your ears don’t send clear signals to your brain, your brain compensates by working harder to fill in the gaps, much like how straining to hear a conversation in a noisy restaurant leaves you mentally exhausted. The 2026 research published in multiple journals provides concrete numbers. Among older adults studied, 36 percent of those prescribed and using hearing aids developed cognitive impairment over the study period, compared to 42 percent of those without hearing aids.
While that might sound modest, it represents a 15 percent lower risk—a meaningful difference when applied across millions of aging adults. The dose-response relationship is equally important: people who used their hearing aids consistently saw steadier decreases in dementia risk, while those who wore them sporadically saw less benefit. Age appears to matter significantly. Younger adults diagnosed with hearing loss before age 70 who used hearing aids showed a 61 percent lower dementia risk compared to those who didn’t treat their hearing loss. This suggests that catching and treating hearing loss earlier in life may offer even greater protective benefits for long-term brain health.
The ACHIEVE Study: Why These Numbers Matter (and Their Limitations)
The ACHIEVE study is the gold standard for hearing loss and dementia research because it was a randomized controlled trial—the most rigorous type of scientific study—conducted across four major U.S. medical centers with 977 participants. Unlike observational studies that simply track what happens, a randomized trial assigns some people to get hearing aids and others not to, controlling for other variables that might affect cognition. Published in The Lancet in 2024, the study followed participants for three years, long enough to measure meaningful changes in cognitive function. However, it’s important to understand what the study actually found versus what headlines sometimes claim. For the overall group of all 977 participants, hearing aids did not produce a statistically significant cognitive benefit across the board.
But when researchers looked specifically at people already at increased risk for dementia—those with cognitive complaints, family history, or other risk factors—hearing aids reduced cognitive decline by nearly 50 percent (48% to be precise). This is a critical distinction: hearing aids appear to work best as a dementia prevention tool for people who are already vulnerable, not as a universal brain protection for everyone with hearing loss. The researchers were careful to note something important: hearing aids should not be marketed primarily as a dementia prevention device. Instead, they should be promoted for what they genuinely help with—improving quality of life, social engagement, and communication. The cognitive benefits appear to be a valuable byproduct, but overselling hearing aids as dementia prevention could mislead people or create unrealistic expectations. People need to treat hearing loss because untreated hearing loss itself reduces quality of life, and the potential cognitive benefits are an additional reason to address it seriously.
Recent 2026 Findings: Newer Evidence on Hearing Aid Effectiveness
The research landscape shifted noticeably in February 2026 when several new studies confirmed and expanded on the ACHIEVE findings. The consistency across these newer studies is noteworthy: they all point in the same direction, suggesting that the connection between hearing treatment and dementia risk reduction is real, not a fluke. ScienceDaily reported on research showing that the 15 percent risk reduction associated with hearing aids wasn’t an outlier—it was part of a pattern seen across different populations. What makes the 2026 research particularly valuable is that it examined adherence more carefully. The studies tracked not just whether people were prescribed hearing aids, but how consistently they actually wore them.
Those who wore hearing aids regularly showed much better outcomes than those who wore them occasionally. For example, someone who wore hearing aids five or six days a week showed measurably better cognitive outcomes than someone who wore them only one or two days weekly. This dose-response relationship makes biological sense—the more consistently you reduce the cognitive strain of hearing loss, the more your brain benefits. The research also revealed important variations by age group. Younger older adults (in their early 70s) showed particularly strong benefits from consistent hearing aid use, which has implications for future prevention strategies. As hearing loss becomes more common in younger age groups due to noise exposure and other factors, early intervention might offer substantial long-term cognitive protection.
Who Benefits Most From Hearing Loss Treatment?
The evidence suggests that certain people stand to gain the most from treating hearing loss. Those at already-elevated dementia risk—people with a family history of Alzheimer’s disease, those with subjective cognitive complaints, or those with other vascular or metabolic risk factors—appear to see the strongest cognitive benefits from hearing aids. If you fit this profile, treating hearing loss moves from a quality-of-life issue to a more urgent health priority. Age also plays a role. Younger older adults, particularly those under 75, seem to gain more cognitive benefit from hearing aids than those in their 80s, possibly because their brains are more plastic and responsive to reduced cognitive load.
Someone diagnosed with hearing loss at age 65 and prescribed hearing aids then might expect greater long-term cognitive protection than someone first treated at age 85, though both benefit. The comparison to other dementia risk factors helps put this in perspective. Hearing loss treatment is unique because it’s one of the few modifiable risk factors that’s also highly reversible. Unlike some dementia risks—genetic predisposition, for instance—hearing loss can be treated. This makes it one of the more actionable recommendations aging adults can address.
When and Why Hearing Aids Might Not Be the Complete Answer
It’s essential to recognize what hearing aids cannot do. They cannot guarantee protection against dementia. The research shows risk reduction, not prevention. Someone with excellent hearing aid compliance might still develop Alzheimer’s disease or another form of dementia, particularly if other risk factors are present. Treating hearing loss is one piece of dementia prevention, not a magic solution. Additionally, hearing aids work best when the hearing loss is the primary problem. For people whose hearing loss stems from damage to the inner ear (sensorineural hearing loss), hearing aids amplify sound and help.
But for those with other types of age-related cognitive concerns—such as uncontrolled hypertension, diabetes, or sleep apnea—treating hearing loss alone won’t address these other contributors to dementia risk. A comprehensive approach matters. Someone with hearing loss, high blood pressure, and poor sleep habits needs to tackle all three, not just the hearing loss. Compliance is another real limitation. While studies show benefits for consistent users, many people struggle with hearing aid adjustment. The devices require proper fitting, regular cleaning, battery management, and a period of adaptation while your brain learns to process amplified sound again. People who give up after a few weeks or months won’t experience the cognitive benefits that consistent users do.
Beyond Hearing Aids: Surgical Options and Other Treatments
For some people, hearing aids aren’t the only option. A 2026 paper published in Frontiers in Dementia examined people with treatable middle ear conditions—problems like otosclerosis or conductive hearing loss from ear drum perforation. When these conditions were surgically corrected, the elevated dementia risk they carried either significantly decreased or disappeared entirely.
This suggests that the pathway to dementia risk may partly involve the chronic cognitive strain of untreated hearing loss, and resolving that strain—whether through hearing aids, surgery, or cochlear implants—offers protection. For those candidates, surgical options might provide more complete restoration of normal hearing compared to hearing aids, which amplify but cannot fully restore the natural hearing experience. Someone with early-stage otosclerosis might benefit from stapes surgery that restores bone conduction, potentially avoiding decades of hearing aid dependence while also protecting cognitive function.
What This Means for Your Brain Health Going Forward
The trajectory of this research suggests that hearing health will become an increasingly important part of dementia prevention strategies. Public health organizations are beginning to recommend regular hearing screening starting at age 50, treating hearing loss early rather than waiting until it becomes severe. If you’re in your 60s or 70s, hearing screening has become as important as blood pressure checks and cholesterol monitoring.
The broader lesson is that brain health isn’t just about cognition-specific interventions like puzzles or memory games. It’s about maintaining the systems that support cognitive function—and hearing is one of those foundational systems. Taking action on hearing loss now, while you’re still healthy and your brain is responsive to interventions, may offer decades of cognitive protection.
Conclusion
The evidence from the ACHIEVE study and recent 2026 research makes a compelling case for treating hearing loss seriously as a dementia prevention strategy. For people at high risk for dementia, hearing aids can reduce cognitive decline by roughly 50 percent. Even for those at standard risk, consistent use of hearing aids correlates with a meaningful 15 percent reduction in dementia risk. These aren’t trivial numbers when considering that dementia affects millions.
The path forward is clear: if you have hearing loss, get it treated—not primarily because it will prevent dementia, but because untreated hearing loss reduces quality of life and harms social engagement. The cognitive and brain-protective benefits are an important additional reason to act now. Talk with your doctor about hearing screening if you’re over 50, work with an audiologist on a proper fitting if hearing aids are recommended, and prioritize consistent use once you have them. Your hearing today is an investment in your cognition and independence tomorrow.
You Might Also Like
- treating sleep apnea Could Reduce Dementia Risk by 67 Percent New Study Shows
- learning a new language Could Reduce Dementia Risk by 67 Percent New Study Shows
- deep breathing Could Reduce Dementia Risk by 25 Percent New Study Shows
For more, see Alzheimer’s Association — clinical trials.
